ArticleJAMA network open2020

Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma.

Gary H Lyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.